AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
NanoViricides Statistics
Share Statistics
NanoViricides has 14.35M shares outstanding. The number of shares has increased by 21.8% in one year.
Shares Outstanding | 14.35M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 21.44% |
Owned by Institutions (%) | n/a |
Shares Floating | 13.78M |
Failed to Deliver (FTD) Shares | 585 |
FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 339.33K, so 2.37% of the outstanding shares have been sold short.
Short Interest | 339.33K |
Short % of Shares Out | 2.37% |
Short % of Float | 2.46% |
Short Ratio (days to cover) | 1.92 |
Valuation Ratios
The PE ratio is -2.65 and the forward PE ratio is -2.37.
PE Ratio | -2.65 |
Forward PE | -2.37 |
PS Ratio | 0 |
Forward PS | 5.6 |
PB Ratio | 1.92 |
P/FCF Ratio | -3.39 |
PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NanoViricides Inc..
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.66, with a Debt / Equity ratio of 0.
Current Ratio | 3.66 |
Quick Ratio | 3.66 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.72% and return on capital (ROIC) is -74.29%.
Return on Equity (ROE) | -0.72% |
Return on Assets (ROA) | -0.65% |
Return on Capital (ROIC) | -74.29% |
Revenue Per Employee | 0 |
Profits Per Employee | -1.18M |
Employee Count | 7 |
Asset Turnover | 0 |
Inventory Turnover | 0 |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 11.32% in the last 52 weeks. The beta is 0.97, so NanoViricides 's price volatility has been higher than the market average.
Beta | 0.97 |
52-Week Price Change | 11.32% |
50-Day Moving Average | 1.42 |
200-Day Moving Average | 1.68 |
Relative Strength Index (RSI) | 31.97 |
Average Volume (20 Days) | 286.40K |
Income Statement
Revenue | n/a |
Gross Profit | -759.01K |
Operating Income | -8.52M |
Net Income | -8.29M |
EBITDA | -7.76M |
EBIT | n/a |
Earnings Per Share (EPS) | -0.7 |
Balance Sheet
The company has 4.80M in cash and 0 in debt, giving a net cash position of 4.80M.
Cash & Cash Equivalents | 4.80M |
Total Debt | 0 |
Net Cash | 4.80M |
Retained Earnings | -139.37M |
Total Assets | 11.74M |
Working Capital | 2.41M |
Cash Flow
In the last 12 months, operating cash flow was -6.32M and capital expenditures -156.56K, giving a free cash flow of -6.47M.
Operating Cash Flow | -6.32M |
Capital Expenditures | -156.56K |
Free Cash Flow | -6.47M |
FCF Per Share | -0.55 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NNVC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -59.32% |
FCF Yield | -38.39% |
Analyst Forecast
The average price target for NNVC is $6.5, which is 450.8% higher than the current price. The consensus rating is "Buy".
Price Target | $6.5 |
Price Target Difference | 450.8% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Stock Splits
The last stock split was on Sep 24, 2019. It was a backward split with a ratio of 1:20.
Last Split Date | Sep 24, 2019 |
Split Type | backward |
Split Ratio | 1:20 |
Scores
Altman Z-Score | -11.13 |
Piotroski F-Score | 1 |